|
|
|
Insider
Information: |
Formela Jean Francois |
Relationship: |
|
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
7,291 |
|
Indirect Shares
|
24,762,873 |
|
|
Direct
Value |
$165,724 |
|
|
Indirect Value
|
$273,012,653 |
|
|
Total
Shares |
24,770,164 |
|
|
Total
Value |
$273,178,377 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
179.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Decode Genetics Inc |
DCGN |
Director |
2003-09-09 |
0 |
2003-12-11 |
0 |
Premium* |
|
Exelixis Inc |
EXEL |
Director |
2003-11-13 |
0 |
2005-09-07 |
584,519 |
Premium* |
|
Nxstage Medical, Inc. |
NXTM |
Director, 10% Owner |
|
0 |
2006-05-26 |
2,592,126 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director, 10% Owner |
2006-02-01 |
0 |
2006-02-06 |
2,485,068 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Director, 10% Owner |
2006-10-31 |
0 |
2006-10-31 |
1,968,670 |
Premium* |
|
Nuvelo Inc |
ABIO |
Director, 10% Owner |
|
0 |
2012-10-22 |
1,579,542 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director, 10% Owner |
|
0 |
2011-08-02 |
5,393,178 |
Premium* |
|
Egalet Corp |
EGLT |
Director, 10% Owner |
|
0 |
2014-02-11 |
2,460,949 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2022-06-14 |
7,291 |
2021-06-28 |
10,000 |
Premium* |
|
Spero Therapeutics Inc |
SPRO |
Director |
2017-11-06 |
0 |
2017-11-06 |
2,408,128 |
Premium* |
|
Translate Bio, Inc. |
TBIO |
Director |
2018-07-02 |
0 |
2021-09-14 |
0 |
Premium* |
|
Ikena Oncology, Inc. |
IKNA |
Director |
|
0 |
2021-12-14 |
4,143,544 |
Premium* |
|
Korro Bio |
KRRO |
|
2023-11-03 |
0 |
2024-04-22 |
1,137,149 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-22 |
4 |
S |
$4.36 |
$326,978 |
I/I |
(75,000) |
195,291 |
|
- |
|
NXTM |
Nxstage Medical, Inc. |
Director |
|
2005-10-27 |
4 |
B |
$10.00 |
$999,230 |
I/I |
99,923 |
218,944 |
2.25 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2004-08-11 |
4 |
S |
$6.80 |
$1,360,000 |
I/I |
(200,000) |
230,692 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-19 |
4 |
S |
$4.04 |
$343,247 |
I/I |
(85,000) |
232,791 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-18 |
4 |
S |
$4.00 |
$120,000 |
I/I |
(30,000) |
275,291 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-17 |
4 |
S |
$3.99 |
$267,122 |
I/I |
(67,000) |
290,291 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-05 |
4 |
S |
$6.64 |
$29,230 |
I/I |
(4,400) |
297,292 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-03 |
4 |
S |
$7.00 |
$142,759 |
I/I |
(20,400) |
298,758 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-02 |
4 |
S |
$6.99 |
$628,758 |
I/I |
(90,000) |
305,556 |
|
- |
|
EGLT |
Egalet Corp |
Director |
|
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
308,727 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-16 |
4 |
S |
$4.20 |
$420,320 |
I/I |
(100,000) |
323,791 |
|
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
326,524 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-01 |
4 |
S |
$6.64 |
$2,059,547 |
I/I |
(310,000) |
335,547 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-15 |
4 |
S |
$4.13 |
$103,255 |
I/I |
(25,000) |
373,791 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-10 |
4 |
S |
$3.88 |
$69,829 |
I/I |
(18,000) |
386,291 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-09 |
4 |
S |
$3.66 |
$182,785 |
I/I |
(50,000) |
395,291 |
|
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
officerTitle |
|
2006-02-01 |
4 |
B |
$6.00 |
$2,499,996 |
I/I |
416,666 |
416,666 |
2.25 |
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-08 |
4 |
S |
$3.54 |
$176,920 |
I/I |
(50,000) |
420,291 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-11-28 |
4 |
S |
$6.58 |
$658,160 |
I/I |
(100,000) |
438,847 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-05 |
4 |
S |
$3.46 |
$207,498 |
I/I |
(60,000) |
445,291 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-11-26 |
4 |
S |
$6.50 |
$161,947 |
I/I |
(24,900) |
472,170 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-04 |
4 |
S |
$3.47 |
$52,050 |
I/I |
(15,000) |
475,291 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-11-25 |
4 |
S |
$6.73 |
$253,566 |
I/I |
(37,700) |
480,467 |
|
- |
|
DCGN |
Decode Genetics Inc |
Director |
|
2003-09-03 |
4 |
S |
$3.50 |
$61,250 |
I/I |
(17,500) |
482,791 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-11-24 |
4 |
S |
$6.40 |
$704,462 |
I/I |
(110,000) |
493,030 |
|
- |
|
96 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|